Yanov Yu K, Ryazantsev S V, Artyushkin S A, Fanta I V, Pavlova S S
Saint Petersburg Research Institute of Ear, Throat, Nose and Speech, Ministry of Heath of the Russian Fderation, Saint Petersburg, Russia, 190013.
I.I. Mechnikov North-Western State Medical University, Ministry of Heath of the Russian Federation, Saint Petersburg, Russia, 191015.
Vestn Otorinolaringol. 2018;83(3):56-60. doi: 10.17116/otorino201883356.
The main objectives of the present article were to systematize the modern views of the causes and risk factors of allergic rhinitis, to clarify the manner of its development, to define the leading etiological mechanism underling the pathogenesis of this condition, to consider the methods used for the diagnostics and the treatment of this disease, and to sum up the clinical experience with the use of Levocetirizine (Allerwey) for the management of allergic rhinitis. Special attention is given to the achievement and the maintenance of control of the persistent or intermittent forms of allergic rhinitis and to approaches to its treatment based on the medications registered in the Russian Federation.
本文的主要目的是系统化过敏性鼻炎病因和危险因素的现代观点,阐明其发展方式,确定该疾病发病机制的主要病因机制,探讨用于诊断和治疗该疾病的方法,并总结使用左西替利嗪(Allerwey)治疗过敏性鼻炎的临床经验。特别关注持续性或间歇性过敏性鼻炎控制的达成与维持,以及基于俄罗斯联邦注册药物的治疗方法。